<< Geriatric care intervention appears to provide some benefits for low-income seniors | GlaxoSmithKline response to JAMA article on ICES retrospective analysis >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Dansk | Nederlands | Finnish | Ελληνικά | עִבְרִית | Русский | Svenska | Polski

'Informed cohort' provides personal stake in genetics research

Published on December 13, 2007 at 1:09 AM · No Comments

Patients are often reluctant to give up DNA samples for research, not knowing what the information will be used for and feeling there's no personal benefit to them.

The heads of the Genomics and Informatics programs at Children's Hospital Boston argue that the current way of doing genetic research -- with completely anonymized data to protect patient privacy -- is actually paternalistic and detrimental to patients, who could otherwise be getting back vital health information.

They've created a mechanism for allowing patients -- if they wish -- to be alerted to discoveries that may affect them (say, a genetic variant in their DNA, predicting benefit from a particular medication) while still remaining anonymous. The authors believe this so-called "Informed Cohort" design is ethically superior to the current way of doing research, making patients full partners in the enterprise, and more likely to participate in studies because they have more to gain. For example, they could benefit from incidental findings that were never anticipated when data were first gathered. Children's Hospital Boston has committed to piloting the Informed Cohort in several of its clinics -- getting DNA from all comers - with the hope of eventually inviting all hospital patients to opt in.

http://www.childrenshospital.org/

Posted in: Medical Research News

Tags: ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading